Sodium Acetate
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hospira, Inc. | brand | 6 | SUPPLYING |
| Amneal Pharmaceuticals Private Limited | unknown | 3 | SUPPLYING |
| MILLA PHARMACEUTICALS INC. | unknown | 2 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose. — Recalling firm: Fresenius Kabi USA, LLC — Nationwide USA
Sodium Acetate Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Total Parenteral Nutrition.
Sodium Acetate Injection — reported in shortage by Milla Pharmaceuticals. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition.
Sodium Acetate Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Endocrinology/Metabolism, Gastroenterology, Pediatric, Total Parenteral Nutrition.
Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial. — Recalling firm: Hospira Inc. — Nationwide and Puerto Rico
